Industry
Ikena Oncology Cuts Hippo Pathway Inhibitor, Lays Off Half of Staff in Strategic Reprioritization
Ikena Oncology, Hippo pathway inhibitor, TEAD1-selective, layoffs, strategic update, biotech industry, clinical trials, cancer treatment
Cytokinetics’ Royalty Agreement Dampens Merger and Acquisition Hopes, Say Investors
Cytokinetics, Merger and Acquisition (M&A), Royalty Agreement, Investors, Biotech Industry
Biopharma Downsizing Trends 2024: Major Companies Adjusting Workforce
Biopharma, layoffs, downsizing, workforce reduction, Evotec, Lyra Therapeutics, Takeda Pharmaceuticals, industry trends, 2024
BIO Undergoes Transformative Restructuring for Future Growth
BIO, lobbying group, reorganization, restructuring, layoffs, future growth, transformation, biotechnology industry.
Biopharma Downsizing Trend 2024: Erasca, Bolt, Tenaya, and Other Industry Players Reduce Workforce
Biopharma, Layoffs, Downsizing, Erasca, Bolt, Tenaya, Industry Trends, Workforce Reduction, 2024
Attovia Secures $105M for Multiple Trials of Innovative Industrial and Institutional Biologics
Attovia, biologics, industrial and institutional (I&I), crossover investors, funding, clinical trials
Reunion Neuroscience Secures $103 Million to Advance Psychedelic Therapies for Patients
Reunion Neuroscience, psychedelic therapies, mental health, fundraising, clinical trials, mental health treatments, alternative therapies, mental health innovation, patient care, biotech industry.
Lonza closes plant in China but CDMO’s sales signal an uptick in industry
Plants, China, Signal, Industry, Congestive heart failure